Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well once trials are completed , we see big money . 20 years young.
In response to PM.... Up a penny or two ;)
Lol I have a buttload at .0007 that I bought a while back.
Congrats on those. Unfortunately, I'm a .0007 person lol!
We start seeing revenues in the Jan/Feb 10-Q report right?
Those companies did not have "nothing" at the time of their low prices. Just a lot more of doubters than optimists. Elite is basically a new company making a name for itself after it's financial meltdown that almost put it bankrupt. This new Elite has a great management team, huge pipeline to sustain a positive cash flow, and has their CEO and Chairman purchasing an enormous amount of shares to back up their confidence.
Much appreciated. This company has a very bright future. I can probably get my Nissan GTR by the time I'm out of Graduate School lol.
Smurf, did you jump into IG?
I still haven't jumped back in yet. I do apologize for saying this, but I don't mind this walk down. Getting ready to throw a big amount in before today ends.
Well factor in the share count. JAZZ and DNDN didn't look so pretty at one point either. I'm not saying Elite will 100 fold like JAZZ or DNDN at one point..... But Elites ART line is still not well known versus other Nasdaq companies. Just something to consider.
Well that's interesting. At least now that kills the bashers theory that the forecast was from the days when Elite was in dollar land. This shows that these forecast estimations are current and we have some great potential gains in the near future!
Looks like the 4th run is in progress. PR for trials and BOOM. New highs.
Waiting waiting. No pain, no gain.... It hunk we know from experience.
... It's something about that generic life lol
I'm happy that a lot of longs made a lot of money. But I am also hoping that this drops some more so that I can get back in at a lower price. I sold half of my holding the morning it got approval lol.
They have a huge pipeline and they're submitting ANDA's at a fast rate. Though the products don't have the same market size as IPCI's drugs, they are consistently growing and will most likely hit a profit next quarter for the first time. I got in at about $2.
Oh my god... Not you again... Lol!
Hey there Doog,
I don't know if you saw, but I sold half of my position the morning the approval happened. Missed out on the huge 160%+ day. I'm seeing if this will drop a little bit more and I will jump back in.
GEE I hope it does go back down. i really want to buy back some more lol :(
Exactly bro. I'm glad that it finally happened and happier that you and the other fellow longs got what you all deserve.
I sold half of my position in IPCI this morning . Wahhhhhh
... I made the biggest mistake....
I was waiting for a question the whole time lol
This lady "SALLY" in the Q&A is BADASS LOLOL
I never said that or supported those "statements" lol
CHALLENGE given by Nasrat to the Elite Employees: FILE NDA BY THE END OF 2014!!!
DECEMBER 5th! TRIALS HAVE INITIATED!!!!
Nasrat: "6 companies were interested. 4 companies had put in offers for the generic partnership, but EPIC was the best option.""Epic had no hidden agendas." "Transferring these products to Epic allows us to focus on our ART technology. We do not have to spend the money and time on these generic drugs." "Waiting until after results before seeking partnerships." "The clinical trials have initiated"
Carter: New stock holder right plan- 8A- filed, Poison Pill, adopted by management when the company feels that it is undervalued and wants to avoid takeover. "We felt that it was prudent to put this in place now to secure our loyal shareholders."
Wow, it was a delight to see this up so much this morning. Lets continue this uptrend back to the levels we were before Adam F. attempted to sabotage this company. Lot of things that will bring great upside to this stock in the future.
I want to see Monday with similar/slightly less gains like today. Then I'll be convinced of another run. Otherwise we'll be in this area of share price for a bit. Still, long term outlook is bright.
Definitely noticed that. Management always keeps their word ;)
Now this is the Catalyst I'm use to seeing!
I never did ignore them. There are lots of successful companies.... And they all started near the bottom too. Companies like JAZZ and ALXN are currently far healthier/superior to Elite. Then I will also say Elite is healthier than a lot of other drug companies.
Look at drug/biotech companies like CTIC, ASTM, ONCY.. Etc. They're losing millions-10 million+ a quarter. Look how long they've been in existence. How much did Elite lose this quarter? Thanks. I think Elite looks healthier than a lot of other drug companies. That's my opinion. You don't have to respect it.
Please don't misinterpret what I said. Elite is healthier than most drug companies.
I'm not going to fluff it, Elite has lost millions and millions. So have hundreds of other companies. Elite has products and future products to be launched which will lighten the loss as each quarter goes by and eventually lead to profitability. I am not living in a fantasy world. I know Elite still has some hurdles, but I am confident that they can overcome them.
Almost all clinical stage companies lose money Dr. A lot of clinical stage companies don't have a consistent gross profit revenue stream. I would take Elite with a small loss every quarter than another Clinical Stage company losing millions a quarter ANY DAY.
We had similar projections lol
I never said these revenues would move the stock. My point is that higher revenues right now means that we are less dependent on borrowing money. I would definitely prefer a clinical company with revenues of 1.2 million and a small loss/gain than a clinical company losing millions a quarter.